Inivata Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 70

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $399M

  • Investors
  • 1

Inivata General Information

Description

Manufacturer of medical test equipment designed to detect cancer using liquid biopsies. The company's equipment helps in harnessing the potential of circulating tumor DNA analysis, monitoring response, and detecting relapse, thereby helping clinicians make informed treatment decisions with respect to the treatment of cancer patients.

Contact Information

Website
www.inivata.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 7020 Kit Creek Road
  • Suite 140
  • Morrisville, NC 27560
  • United States
Primary Industry
Diagnostic Equipment
Acquirer
NeoGenomics
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 7020 Kit Creek Road
  • Suite 140
  • Morrisville, NC 27560
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Inivata Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 18-Jun-2021 $399M Completed Generating Revenue
7. Secondary Transaction - Private 15-Mar-2021 Completed Generating Revenue
6. Later Stage VC (Series C) 04-Feb-2021 Completed Generating Revenue
5. Later Stage VC 03-Jun-2020 Completed Generating Revenue
4. Later Stage VC (Series B) 01-Apr-2019 Completed Generating Revenue
3. Early Stage VC (Series A) 26-Jan-2016 Completed Generating Revenue
2. Early Stage VC 23-Sep-2014 $6.55M $6.55M Completed Startup
1. University Spin-Out 01-Jan-2014 Completed Startup
To view Inivata’s complete valuation and funding history, request access »

Inivata Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C2 Preferred
Series C2 Preferred
Series C1
Series C1
Series B
Series B
Series A 16,591,575 $0.000014 7% $2.59 $2.59 $2.59 25.34%
Preference 4,000,000 $0.000014 5% $1.36 $1.36 $1.36 6.11%
To view Inivata’s complete cap table history, request access »

Inivata Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of medical test equipment designed to detect cancer using liquid biopsies. The company's equipment helps in
Diagnostic Equipment
Morrisville, NC
70 As of 2023

Birmingham, AL
 

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Inivata Competitors (32)

One of Inivata’s 32 competitors is CirculoGene, a Venture Capital-Backed company based in Birmingham, AL.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CirculoGene Venture Capital-Backed Birmingham, AL
Foundation Medicine Formerly VC-backed Boston, MA
BioGenex Laboratories Corporation Fremont, CA
Boreal Genomics Formerly VC-backed Vancouver, Canada
ROCA Test Formerly VC-backed Cambridge, United Kingdom
You’re viewing 5 of 32 competitors. Get the full list »

Inivata Patents

  • 114

    Total Documents Applications and Grants

  • Total Patents Families

  • 48

    Granted

  • 37

    Pending

  • Expiring in next 12 mo

Inivata Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026220337-A1 Systems and methods for hybridizing selective enrichment Pending 16-Apr-2025
US-12509733-B1 Methods and systems for detecting a primary disease Active 07-Apr-2025
US-20260308684-A1 Methods and systems for detecting a primary disease Pending 07-Apr-2025
WO-2026215619-A1 Methods for detecting two types of cancer and deciding on a treatment plan Pending 07-Apr-2025
WO-2026107240-A1 Methods and systems for analyzing low-input samples Pending 15-Nov-2024 C12Q1/6806
To view Inivata’s complete patent history, request access »

Inivata Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Inivata Former Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cambridge Innovation Capital Venture Capital Minority
Cancer Research Technology Venture Capital Minority
Farallon Capital Management Hedge Fund Minority
Future Planet Capital Venture Capital Minority
IP Group Venture Capital Minority
You’re viewing 5 of 14 investors. Get the full list »

Ready to get started?

Request a free trial

Inivata FAQs

  • When was Inivata founded?

    Inivata was founded in 2014.

  • Where is Inivata headquartered?

    Inivata is headquartered in Morrisville, NC.

  • What is the size of Inivata?

    Inivata has 70 total employees.

  • What industry is Inivata in?

    Inivata’s primary industry is Diagnostic Equipment.

  • Is Inivata a private or public company?

    Inivata is a Private company.

  • What is the current valuation of Inivata?

    The current valuation of Inivata is .

  • What is Inivata’s current revenue?

    The current revenue for Inivata is .

  • How much funding has Inivata raised over time?

    Inivata has raised $164M.

  • Who are Inivata’s investors?

    Cambridge Innovation Capital, Cancer Research Technology, Farallon Capital Management, Future Planet Capital, and IP Group are 5 of 14 investors who have invested in Inivata.

  • Who are Inivata’s competitors?

    CirculoGene, Foundation Medicine, BioGenex Laboratories, Boreal Genomics, and ROCA Test are some of the 32 competitors of Inivata.

  • When was Inivata acquired?

    Inivata was acquired on 18-Jun-2021.

  • Who acquired Inivata?

    Inivata was acquired by NeoGenomics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process